tirzepatide and type 1 diabetes in Adults With Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial @DiabetesCareADA 🔻 −10.3 kg in 12 weeks with tirzepatide vs −0.7 kg with placebo (P<0.0001) 🎯 100% ≥5% Bumps and humps in the

This could be a game-changer for people who struggle with weekly injections from similar medications like: Wegovy/Ozempic (semaglutide) Zepbound/Mounjaro (tirzepatide) Other GLP-1 receptor agonists The extended dosing is made possible by the long-lasting antibody structure and slow metabolism

As such, Medicare will not cover it when prescribed for this reason

If you or a close family member have had it, your risk of developing it as well may be higher

Yes, tirzepatide expires, and using it past its expiration date or after improper storage can mean injecting a weakened or ineffective dose without realizing it

At the 12 week mark, participants were still in the dose escalation phase